• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

布美他尼、苄氟噻嗪和肼屈嗪对大鼠尿激肽释放酶排泄的影响。

Effects on rat urinary kallikrein excretion of bumetanide, bendroflumethiazide and hydralazine.

作者信息

Nielsen K, Arrigoni-Martelli E

出版信息

Acta Pharmacol Toxicol (Copenh). 1977 Feb;40(2):267-72. doi: 10.1111/j.1600-0773.1977.tb02077.x.

DOI:10.1111/j.1600-0773.1977.tb02077.x
PMID:576555
Abstract

Single and/or repeated administrations of bumetanide, bendroflumethiazide and hydralazine to normotensive and spontaneously hypertensive rats resulted in an increase of urinary kallikrein excretion. No correlation was found with sodium output. The role of the increased plasma renin activity is discussed and it is suggested that the activation of the renal kallikrein-kinin system is related to the increase in renal blood flow.

摘要

对正常血压和自发性高血压大鼠单次和/或重复给予布美他尼、苄氟噻嗪和肼苯哒嗪,导致尿激肽释放酶排泄增加。未发现与钠排出量相关。讨论了血浆肾素活性增加的作用,并提出肾激肽释放酶-激肽系统的激活与肾血流量增加有关。

相似文献

1
Effects on rat urinary kallikrein excretion of bumetanide, bendroflumethiazide and hydralazine.布美他尼、苄氟噻嗪和肼屈嗪对大鼠尿激肽释放酶排泄的影响。
Acta Pharmacol Toxicol (Copenh). 1977 Feb;40(2):267-72. doi: 10.1111/j.1600-0773.1977.tb02077.x.
2
Investigations on the antihypertensive activity of timolol and bendroflumethiazide and the combination in dogs and rats.噻吗洛尔和苄氟噻嗪及其联合用药对犬和大鼠降压活性的研究。
Acta Pharmacol Toxicol (Copenh). 1976;39(5):500-12. doi: 10.1111/j.1600-0773.1976.tb03200.x.
3
The renal kallikrein-kinin system in spontaneously hypertensive rats.自发性高血压大鼠的肾激肽释放酶-激肽系统
Agents Actions. 1984 Oct;15(3-4):111-8. doi: 10.1007/BF01972335.
4
[Renal kallikrein-kinin system and control of blood pressure (author's transl)].肾激肽释放酶-激肽系统与血压调控(作者译)
Klin Wochenschr. 1979 Oct 1;57(19):1037-45. doi: 10.1007/BF01479989.
5
Investigation of the role of kidney kallikrein on bumetanide induced diuresis in rats.肾脏激肽释放酶在布美他尼诱导大鼠利尿中作用的研究。
Acta Pharmacol Toxicol (Copenh). 1981 Nov;49(5):321-6. doi: 10.1111/j.1600-0773.1981.tb00914.x.
6
Bumetanide induced increase of renal blood flow in conscious dogs and its relation to local renal hormones (PGE, kallikrein and renin).
Acta Pharmacol Toxicol (Copenh). 1976 Mar;38(3):219-28. doi: 10.1111/j.1600-0773.1976.tb03114.x.
7
Effects of bumetanide upon PRA and urinary kallikrein excretion in normal subjects before and after indomethacin treatment.布美他尼对消炎痛治疗前后正常受试者血浆肾素活性(PRA)和尿激肽释放酶排泄的影响。
Minerva Nefrol. 1980 Jul-Sep;27(3):421-4.
8
The supra-additive natriuretic effect addition of bendroflumethiazide and bumetanide in congestive heart failure. Permutation trial tests in patients in long-term treatment with bumetanide.
Am Heart J. 1975 Feb;89(2):163-70. doi: 10.1016/0002-8703(75)90041-1.
9
Renin-angiotensin and kallikrein-kinin systems in sodium homeostasis and hypertension in rats.大鼠钠稳态和高血压中的肾素-血管紧张素系统与激肽释放酶-激肽系统
Clin Sci Mol Med Suppl. 1976 Dec;3:283s-286s.
10
Renal kallikrein-kinin system and prostaglandin in hypertension: their relation to renin-angiotensin-aldosterone system.高血压中的肾激肽释放酶-激肽系统和前列腺素:它们与肾素-血管紧张素-醛固酮系统的关系。
Adv Exp Med Biol. 1979;120B:487-501.

引用本文的文献

1
The renal kallikrein-kinin system in spontaneously hypertensive rats.自发性高血压大鼠的肾激肽释放酶-激肽系统
Agents Actions. 1984 Oct;15(3-4):111-8. doi: 10.1007/BF01972335.
2
Bumetanide. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use.布美他尼。对其药效学、药代动力学特性及治疗用途的综述。
Drugs. 1984 Nov;28(5):426-64. doi: 10.2165/00003495-198428050-00003.
3
Interactions of diuretics with the renal kallikrein-kinin and prostaglandin systems.利尿剂与肾脏激肽释放酶-激肽系统及前列腺素系统的相互作用。
Klin Wochenschr. 1982 Oct 1;60(19):1223-8. doi: 10.1007/BF01716727.
4
Short lasting increase in urinary specific kallikrein activity during long term administration of furosemide.长期服用速尿期间尿中特异性激肽释放酶活性的短暂增加。
Agents Actions. 1987 Dec;22(3-4):302-9. doi: 10.1007/BF02009060.
5
Relationship between kallikrein and PRA after intravenous furosemide.静脉注射呋塞米后激肽释放酶与肾素活性之间的关系。
J Endocrinol Invest. 1979 Apr-Jun;2(2):147-50. doi: 10.1007/BF03349306.
6
[Renal kallikrein-kinin system and control of blood pressure (author's transl)].肾激肽释放酶-激肽系统与血压调控(作者译)
Klin Wochenschr. 1979 Oct 1;57(19):1037-45. doi: 10.1007/BF01479989.
7
The renal kallikrein-kinin system in human and in experimental hypertension.人类及实验性高血压中的肾激肽释放酶-激肽系统
Klin Wochenschr. 1978;56 Suppl 1:113-25. doi: 10.1007/BF01477462.